LILITH: Evaluation of the Effect of Lomitapide Treatment on Major Adverse Cardiovascular Events (MACE) in Patients With Homozygous Familial Hypercholesterolemia (clinicaltrials.gov) - Feb 21, 2026 - P=N/A | N=73 | Active, not recruiting | Sponsor: Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) | Recruiting ➔ Active, not recruiting
Adverse events • Enrollment closed • Cardiovascular • Dyslipidemia • Familial Hypercholesterolemia • Genetic Disorders • Homozygous Familial Hypercholesterolemia • Metabolic Disorders
|